290 related articles for article (PubMed ID: 30340515)
81. PAX2(-)/PAX8(-)/inhibin A(+) immunoprofile in hemangioblastoma: A helpful combination in the differential diagnosis with metastatic clear cell renal cell carcinoma to the central nervous system.
Carney EM; Banerjee P; Ellis CL; Albadine R; Sharma R; Chaux AM; Burger PC; Netto GJ
Am J Surg Pathol; 2011 Feb; 35(2):262-7. PubMed ID: 21263247
[TBL] [Abstract][Full Text] [Related]
82. Hearing preservation surgery for small endolymphatic sac tumors in patients with von Hippel-Lindau syndrome.
Megerian CA; Haynes DS; Poe DS; Choo DI; Keriakas TJ; Glasscock ME
Otol Neurotol; 2002 May; 23(3):378-87. PubMed ID: 11981399
[TBL] [Abstract][Full Text] [Related]
83. Endolymphatic sac tumor located around semicircular canals.
Wada T; Fujisaki T; Satoh H; Takahashi S
Auris Nasus Larynx; 2006 Jun; 33(2):173-7. PubMed ID: 16466878
[TBL] [Abstract][Full Text] [Related]
84. PAX-2 is a helpful marker for diagnosing metastatic renal cell carcinoma: comparison with the renal cell carcinoma marker antigen and kidney-specific cadherin.
Ozcan A; Zhai Q; Javed R; Shen SS; Coffey D; Krishnan B; Truong LD
Arch Pathol Lab Med; 2010 Aug; 134(8):1121-9. PubMed ID: 20670131
[TBL] [Abstract][Full Text] [Related]
85. Somatic von Hippel-Lindau gene mutations detected in sporadic endolymphatic sac tumors.
Vortmeyer AO; Huang SC; Koch CA; Governale L; Dickerman RD; McKeever PE; Oldfield EH; Zhuang Z
Cancer Res; 2000 Nov; 60(21):5963-5. PubMed ID: 11085513
[TBL] [Abstract][Full Text] [Related]
86. Cochlear implantation in a bilateral endolymphatic sac tumor patient. A case report.
Boccio CM; Raffo GM; Parsini C
Int J Pediatr Otorhinolaryngol; 2007 Nov; 71(11):1803-7. PubMed ID: 17825433
[TBL] [Abstract][Full Text] [Related]
87. Endolymphatic sac tumors: histopathologic confirmation, clinical characterization, and implication in von Hippel-Lindau disease.
Megerian CA; McKenna MJ; Nuss RC; Maniglia AJ; Ojemann RG; Pilch BZ; Nadol JB
Laryngoscope; 1995 Aug; 105(8 Pt 1):801-8. PubMed ID: 7630290
[TBL] [Abstract][Full Text] [Related]
88. Endolymphatic sac tumour: case report and literature review.
Virk JS; Randhawa PS; Saeed SR
J Laryngol Otol; 2013 Apr; 127(4):408-10. PubMed ID: 23448594
[TBL] [Abstract][Full Text] [Related]
89. Endolymphatic Sac Tumor in Two Dogs.
Barnes KJ; Clear V; Youmans K; Hardcastle MR; Nelson N; Petersen A; Kiupel M
Vet Pathol; 2017 Jul; 54(4):683-685. PubMed ID: 28171732
[TBL] [Abstract][Full Text] [Related]
90. The endolymphatic sac tumor: challenges in the eradication of a localized disease.
Sykopetrites V; Piras G; Giannuzzi A; Caruso A; Taibah A; Sanna M
Eur Arch Otorhinolaryngol; 2021 Jul; 278(7):2297-2304. PubMed ID: 32889625
[TBL] [Abstract][Full Text] [Related]
91. Endolymphatic sac papillary tumor: a case report and review.
Yilmaz I; Bolat F; Demirhan B; Aydin V; Ozluoglu LN
Auris Nasus Larynx; 2008 Jun; 35(2):276-81. PubMed ID: 17855033
[TBL] [Abstract][Full Text] [Related]
92. [Endolymphatic sac tumor with von Hippel-Lindau disease: report of two cases with testing of von Hippel-Lindau gene].
Su Y; Shen WD; Wang CC; Han WJ; Liu J; Hou ZH; Song ZG; Huang DL; Han DY; Yang SM
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Nov; 48(11):913-8. PubMed ID: 24444636
[TBL] [Abstract][Full Text] [Related]
93. Diagnostic implications of transcription factor Pax 2 protein and transmembrane enzyme complex carbonic anhydrase IX immunoreactivity in adult renal epithelial neoplasms.
Gupta R; Balzer B; Picken M; Osunkoya AO; Shet T; Alsabeh R; Luthringer D; Paner GP; Amin MB
Am J Surg Pathol; 2009 Feb; 33(2):241-7. PubMed ID: 18941400
[TBL] [Abstract][Full Text] [Related]
94. Sporadic Endolymphatic Sac Tumor-A Very Rare Cause of Hearing Loss, Tinnitus, and Dizziness.
Schnack DT; Kiss K; Hansen S; Miyazaki H; Bech B; Caye Thomasen P
J Int Adv Otol; 2017 Aug; 13(2):289-291. PubMed ID: 28716765
[TBL] [Abstract][Full Text] [Related]
95. Endolymphatic Sac Tumor in von Hippel-Lindau Disease: A Rare Case Report.
Biswas R; Kumari K; Gupta S; Haresh KP; Halder A; Rath GK
J Pediatr Neurosci; 2017; 12(3):294-297. PubMed ID: 29204213
[TBL] [Abstract][Full Text] [Related]
96. [Papillary tumor of the inner ear: adenoma or carcinoma?].
Hattenberger S; Schroeder HG; Sollmann WP; Donhuijsen K
HNO; 2002 Feb; 50(2):161-4. PubMed ID: 12080627
[TBL] [Abstract][Full Text] [Related]
97. Clear cell papillary renal cell carcinoma-like tumors in patients with von Hippel-Lindau disease are unrelated to sporadic clear cell papillary renal cell carcinoma.
Williamson SR; Zhang S; Eble JN; Grignon DJ; Martignoni G; Brunelli M; Wang M; Gobbo S; Baldridge LA; Cheng L
Am J Surg Pathol; 2013 Aug; 37(8):1131-9. PubMed ID: 23648463
[TBL] [Abstract][Full Text] [Related]
98. Deregulation of PAX2 expression in renal cell tumours: mechanisms and potential use in differential diagnosis.
Patrício P; Ramalho-Carvalho J; Costa-Pinheiro P; Almeida M; Barros-Silva JD; Vieira J; Dias PC; Lobo F; Oliveira J; Teixeira MR; Henrique R; Jeronimo C
J Cell Mol Med; 2013 Aug; 17(8):1048-58. PubMed ID: 23890189
[TBL] [Abstract][Full Text] [Related]
99. Useful immunohistochemical markers in differentiating hemangioblastoma versus metastatic renal cell carcinoma.
Rivera AL; Takei H; Zhai J; Shen SS; Ro JY; Powell SZ
Neuropathology; 2010 Dec; 30(6):580-5. PubMed ID: 20374497
[TBL] [Abstract][Full Text] [Related]
100. PAX2 and PAX8 expression in primary and metastatic renal tumors: a comprehensive comparison.
Ozcan A; de la Roza G; Ro JY; Shen SS; Truong LD
Arch Pathol Lab Med; 2012 Dec; 136(12):1541-51. PubMed ID: 23194047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
